Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Type II diabetes is characterized by increased oxidative stress, endothelial dysfunction and hypertension. We investigated whether short-term treatment with oral vitamin C reduces oxidative stress and improves endothelial function and blood pressure in subjects with Type II diabetes. Subjects (n = 35) received vitamin C (1.5g daily in three doses) or matching placebo for 3 weeks in a randomized, double-blind, parallel-group design. Plasma concentrations of 8-epi-prostaglandin F2α (8-epi-PGF2α), a non-enzymically derived oxidation product of arachidonic acid, were used as a marker of oxidative stress. Endothelial function was assessed by measuring forearm blood flow responses to brachial artery infusion of the endothelium-dependent vasodilator acetylcholine (with nitroprusside as an endothelium-independent control) and by the pulse wave responses to systemic albuterol (endothelium-dependent vasodilator) and glyceryl trinitrate (endothelium-independent vasodilator). Plasma concentrations of vitamin C increased from 58±6 to 122±10μmol/l after vitamin C, but 8-epi-PGF2α levels (baseline, 95±4pg/l; after treatment, 99±5pg/l), blood pressure (baseline, 141±5/80±2mmHg; after treatment, 141±5/81±3mmHg) and endothelial function, as assessed by the systemic vasodilator response to albuterol and by the forearm blood flow response to acetylcholine, were not significantly different from baseline or placebo. Thus treatment with vitamin C (1.5 g daily) for 3 weeks does not significantly improve oxidative stress, blood pressure or endothelial function in patients with Type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance
Levine, M., Conry-Cantilena, C., Wang, Y., Welch, R. W., Washko, P. W., Dhariwal, K. R., Park, J. B., Lazarev, A., Graumlich, J. F., King, J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3704 · Cited by 1,325
Ascorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Levine, G. N., Frei, B., Koulouris, S. N., Gerhard, M. D., Keaney, J. F., & Vita, J. A. (1996) · Circulation · doi:10.1161/01.cir.93.6.1107 · Cited by 582
Antioxidant Vitamin C Improves Endothelial Dysfunction in Chronic Smokers
Heitzer, T., Just, H., & Mu¨nzel, T. (1996) · Circulation · doi:10.1161/01.cir.94.1.6 · Cited by 554
Jackson, T. S., Xu, A., Vita, J. A., & Keaney, J. F. (1998) · Circulation Research · doi:10.1161/01.res.83.9.916 · Cited by 400
Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus
Gopaul, N. K., Änggård, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., & Nourooz-Zadeh, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00649-t · Cited by 390
Retsky, K. L., Freeman, M. W., & Frei, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54075-8 · Cited by 271
How does ascorbic acid prevent endothelial dysfunction?
May, J. M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00269-0 · Cited by 260
Rehman, A., Collis, C. S., Yang, M., Kelly, M., Diplock, A. T., Halliwell, B., & Rice-Evans, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8592 · Cited by 202
Cited by
Halliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
“…al., 1999; Wilkinson et al., 1999; May, 2000; Beckman et al., 2001; Duffy et al., 2001; Pleiner et al., 2002; Heiss et al., 2003), although negative reports are now accumulating (e.g. Darko et al., 2002; Singh et al., 2002; Svetkey & Loria, 2002; Widlansky et al., 2004; our unpublished date).”
BackgroundVitamins C and E: Beneficial effects from a mechanistic perspective
Traber, M. G., & Stevens, J. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.017 · Cited by 1,076
“5 g daily) in type II diabetics for 3 weeks did not improve LPO biomarkers [163].”
BackgroundBjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176.pub2 · Cited by 924
A review on the role of antioxidants in the management of diabetes and its complications
Rahimi, R., Nikfar, S., Larijani, B., & Abdollahi, M. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.07.002 · Cited by 889
Role of insulin resistance in endothelial dysfunction
Muniyappa, R., & Sowers, J. R. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9229-1 · Cited by 539
“Insulin sensitizers and endothelial dysfunction Calorie restriction and physical exercise, interventions known to improve insulin sensitivity, also improves endothelial dysfunction [57–69].”
Reactive oxygen species and vascular biology: implications in human hypertension
Touyz, R. M., & Briones, A. M. (2011) · Hypertension Research · doi:10.1038/hr.2010.201 · Cited by 470
Lipid Peroxidation in Diabetes Mellitus
Davì, G., Falco, A., & Patrono, C. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.256 · Cited by 376
Estresse oxidativo: conceito, implicações e fatores modulatórios
Barbosa, K. B. F., Costa, N. M. B., Alfenas, R. D. C. G., De Paula, S. O., Minim, V. P. R., & Bressan, J. (2010) · Revista de Nutrição · doi:10.1590/s1415-52732010000400013 · Cited by 355
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007176 · Cited by 302
Juraschek, S. P., Guallar, E., Appel, L. J., & Miller, E. R. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.027995 · Cited by 294
F 2 -Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
Basu, S. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1956 · Cited by 268
Oxidative stress as a therapeutic target in diabetes: revisiting the controversy
Wiernsperger, N. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70072-1 · Cited by 257
An Integrated View of Insulin Resistance and Endothelial Dysfunction
Muniyappa, R., Iantorno, M., & Quon, M. J. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.001 · Cited by 220
Antioxidants in the Treatment of Diabetes
Golbidi, S., Alireza Ebadi, S., & Laher, I. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794940729 · Cited by 197
Natural Antioxidants and Hypertension: Promise and Challenges
Kizhakekuttu, T. J., & Widlansky, M. E. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00137.x · Cited by 174
“Many [83–86], but not all [87], show modest reductions in blood pressure in both normotensive and hypertensive populations.”
BackgroundMcCall, D. O., McGartland, C. P., McKinley, M. C., Patterson, C. C., Sharpe, P., McCance, D. R., Young, I. S., & Woodside, J. V. (2009) · Circulation · doi:10.1161/circulationaha.108.831297 · Cited by 161
Teng, H., & Chen, L. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1129309 · Cited by 162
Song, Y., Cook, N. R., Albert, C. M., Van Denburgh, M., & Manson, J. E. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27491 · Cited by 162
Metadata
- Authors
- DARKO, D., DORNHORST, A., KELLY, F. J., RITTER, J. M., & CHOWIENCZYK, P. J.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2002-08-23
- Volume
- 103
- Issue
- 4
- Pages
- 339-344
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W181037183
- Cited by
- 137
- References
- 9
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.